SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001372514-23-000152
Filing Date
2023-10-13
Accepted
2023-10-13 17:09:18
Documents
4
Effectiveness Date
2023-10-13

Document Format Files

Seq Description Document Type Size
1 S-8 kiorapharmaceuticalsinc-sx.htm S-8 89805
2 EX-5.1 exhibit51-legalopinion.htm EX-5.1 9384
3 EX-23.1 exhibit231-auditorconsent.htm EX-23.1 3638
4 EX-FILING FEES exhibit107-calculationoffi.htm EX-FILING FEES 25253
  Complete submission text file 0001372514-23-000152.txt   129207
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-274974 | Film No.: 231325653
SIC: 2834 Pharmaceutical Preparations